16-58718562-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000245206.10(GOT2):c.562G>A(p.Gly188Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0736 in 1,596,714 control chromosomes in the GnomAD database, including 4,759 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
ENST00000245206.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GOT2 | NM_002080.4 | c.562G>A | p.Gly188Ser | missense_variant | 5/10 | ENST00000245206.10 | NP_002071.2 | |
GOT2 | NM_001286220.2 | c.433G>A | p.Gly145Ser | missense_variant | 4/9 | NP_001273149.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GOT2 | ENST00000245206.10 | c.562G>A | p.Gly188Ser | missense_variant | 5/10 | 1 | NM_002080.4 | ENSP00000245206 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0572 AC: 8704AN: 152120Hom.: 299 Cov.: 33
GnomAD3 exomes AF: 0.0612 AC: 14703AN: 240202Hom.: 575 AF XY: 0.0647 AC XY: 8393AN XY: 129720
GnomAD4 exome AF: 0.0754 AC: 108880AN: 1444476Hom.: 4460 Cov.: 32 AF XY: 0.0757 AC XY: 54275AN XY: 716772
GnomAD4 genome AF: 0.0571 AC: 8695AN: 152238Hom.: 299 Cov.: 33 AF XY: 0.0563 AC XY: 4187AN XY: 74432
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
GOT2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 14, 2024 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at